Skip to main content
uniQure N.V. logo

uniQure N.V. — Investor Relations & Filings

Ticker · QURE ISIN · NL0010696654 LEI · 724500RPCTZLFYJZ3S98 US Manufacturing
Filings indexed 859 across all filing types
Latest filing 2018-05-01 Capital/Financing Update
Country NL Netherlands
Listing US QURE

About uniQure N.V.

https://www.uniqure.com/

uniQure N.V. is a gene therapy company focused on developing and commercializing treatments for patients with rare and severe diseases. The company utilizes its adeno-associated virus (AAV) based technology platform to create single-administration therapies with the potential for curative results. Its research and development pipeline is concentrated on liver-directed and central nervous system (CNS) disorders, with a key clinical program targeting Huntington's disease. uniQure aims to deliver transformative medicines by translating scientific innovation into viable treatments.

Recent filings

Filing Released Lang Actions
424B5
Capital/Financing Update Classification · 95% confidence The document is a prospectus supplement and accompanying base prospectus related to an offering of ordinary shares. It includes details about the terms of the offering, sales agreement, underwriting commissions, risk factors, and legal matters. The document is filed pursuant to Rule 424(b)(5), which is a SEC rule related to prospectus supplements and amendments. The content focuses on the issuance and sale of shares, updating the maximum number of shares offered, and related distribution plans. There is no financial statement or earnings data, no management discussion of financial results, no audit information, no legal proceedings update, no merger or acquisition details, and no voting or dividend information. This document is clearly a capital raising disclosure related to share issuance and sales. Therefore, the appropriate classification is Capital/Financing Update (CAP). The document length is substantial (15,000 characters), indicating it is the actual filing, not just an announcement. Confidence is high given the clear identification of the document as a prospectus supplement for share offering.
2018-05-01 English
10-Q
Interim / Quarterly Report Q1 2018
2018-04-30 English
8-K
Report Publication Announcement Classification · 95% confidence The document is a Form 8-K current report filed with the SEC, dated April 30, 2018. It references the filing of the definitive proxy on Schedule 14A and mentions the Dutch statutory annual accounts for the year ended December 31, 2017. The document states that the Dutch statutory annual accounts are attached as Exhibit 99.1 and have been made available to shareholders. The text does not contain the full annual report or detailed financial statements but rather announces the filing and availability of the Dutch statutory annual report. The document length is 4504 characters, which is relatively short and consistent with an announcement rather than the full report. Therefore, according to the MENU VS MEAL RULE, this document is an announcement of the report, not the report itself. The appropriate classification is Report Publication Announcement (RPA).
2018-04-30 English
DEF 14A
Proxy Solicitation & Information Statement
2018-04-30 English
PRE 14A
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a Schedule 14A Proxy Statement filed with the SEC, specifically a Preliminary Proxy Statement for the 2018 Annual General Meeting of Shareholders of uniQure N.V. It includes detailed information about the meeting agenda, voting proposals, board appointments, and instructions for shareholders to vote. The document references the proxy materials, including the Proxy Statement and Annual Report on Form 10-K, but it is itself the proxy solicitation document sent to shareholders to inform and request votes for the meeting. This matches the definition of Proxy Solicitation & Information Statement (PSI). The document length is substantial (15,000 characters), and it contains the full proxy statement, not just an announcement or a brief notice. Therefore, the correct classification is PSI with high confidence.
2018-04-20 English
PRIMARY DOCUMENT
Director's Dealing
2018-03-19 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.